R. Molife
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Cancer therapeutics and mechanisms 2
- Oncology 11
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 2
- Cutaneous Melanoma Detection and Management 2
- Co-authors
- Johann S. de Bono (18 shared papers)Gerhardt Attard (6 shared papers)Barry W. Hancock (2 shared papers)Chris Parker (2 shared papers)Paul Lorigan (3 shared papers)Debashis Sarker (4 shared papers)Peter C.C. Fong (2 shared papers)David Olmos (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Molecular Cancer Therapeutics (3 papers)British Journal of Cancer (3 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
R. Molife
23 papers receiving 683 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 162
- Oncology 291
- Pulmonary and Respiratory Medicine 277
- Molecular Biology 300
- Cell Biology 70
Countries citing papers authored by R. Molife
This map shows the geographic impact of R. Molife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Molife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Molife more than expected).
Fields of papers citing papers by R. Molife
This network shows the impact of papers produced by R. Molife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Molife. The network helps show where R. Molife may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Molife, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 194 | |
| 2 | 2008 | 117 | |
| 3 | 2006 | 56 | |
| 4 | 2014 | 54 | |
| 5 | 2002 | 50 | |
| 6 | 2001 | 47 | |
| 7 | 2010 | 45 | |
| 8 | 2006 | 19 | |
| 9 | 2007 | 16 | |
| 10 | 2006 | 16 | |
| 11 | 2023 | 10 | |
| 12 | 2006 | 9 | |
| 13 | 2000 | 9 | |
| 14 | 2006 | 9 | |
| 15 | Safety, tolerability and preliminary efficacy of the anti-IGF-IR monoclonal antibody CP-751,871 in patients with sarcomas and adrenocortical tumors. | 2007 | 7 |
| 16 | 2003 | 7 | |
| 17 | 2006 | 7 | |
| 18 | 2006 | 6 | |
| 19 | An analysis of the risk of toxicity associated with participation in phase 1 oncology trials of novel molecularly targeted agents (mta) at the drug development unit, royal marsden hospital | 2010 | 5 |
| 20 | 2007 | 5 |
About R. Molife
R. Molife is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 24 papers that have together received 694 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Prostate Cancer Treatment and Research (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Peptidase Inhibition and Analysis (2 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Cancer Research (162 citations), Oncology (291 citations), Pulmonary and Respiratory Medicine (277 citations), Molecular Biology (300 citations) and Cell Biology (70 citations). R. Molife has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Johann S. de Bono, Gerhardt Attard, Barry W. Hancock, Chris Parker, Paul Lorigan, Debashis Sarker, Peter C.C. Fong, David Olmos, David P. Dearnaley and Hendrik‐Tobias Arkenau. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, British Journal of Cancer, Annals of Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.